PAHC
Phibro Animal Health Corp. - Ordinary Shares - Class A

273
Mkt Cap
$1.7B
Volume
392,916.00
52W High
$43.65
52W Low
$16.16
PE Ratio
35.46
PAHC Fundamentals
Price
$42.06
Prev Close
$41.86
Open
$41.52
50D MA
$38.80
Beta
1.06
Avg. Volume
349,144.10
EPS (Annual)
$1.19
P/B
5.97
Rev/Employee
$523,723.23
Loading...
Loading...
News
all
press releases
EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash
Edwards Lifesciences Q3 earnings and sales beat estimates on robust TAVR and TMTT growth, though margins take a sharp hit.
Zacks·1d ago
News Placeholder
More News
News Placeholder
New Strong Buy Stocks for Oct. 31: PMT, NWG, and More
PMT, NWG, PAHC, CNC and ACNB have been added to the Zacks Rank #1 (Strong Buy) List on October 31, 2025.
Zacks·1d ago
News Placeholder
Phibro Animal Health Corporation Announces National Launch of Restoris Piezoelectric Dental Gel for Dogs
Phibro Animal Health Corporation is proud to announce the national launch of Restoris piezoelectric dental gel, a revolutionary dental gel designed to treat and support long-term oral health in dogs...
Business Wire·2d ago
News Placeholder
ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash
Align Technology jumps 15% after Q3 earnings and revenues beat estimates, though steep margin declines weigh on results.
Zacks·2d ago
News Placeholder
Sanuwave Health Inc. (SNWV) to Report Q3 Results: Wall Street Expects Earnings Growth
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2d ago
News Placeholder
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 5, 2025, after the market closes. Phibro management will host a...
Business Wire·3d ago
News Placeholder
Phibro Animal Health (PAHC) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3d ago
News Placeholder
CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash
Chemed's Q3 miss sends shares lower as shrinking margins and weaker EPS overshadow steady revenue gains from VITAS and Roto-Rooter.
Zacks·3d ago
News Placeholder
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·4d ago
News Placeholder
LH Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Labcorp's Q3 earnings beat forecasts and margins improve, but a trimmed 2025 sales outlook sends shares down.
Zacks·4d ago

Latest PAHC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.